Loessner D - Search Results

1

Secretome and degradome profiling shows that Kallikrein-related peptidases 4, 5, 6, and 7 induce TGFβ-1 signaling in ovarian cancer cells.

Shahinian H, Loessner D, Biniossek ML, Kizhakkedathu JN, Clements JA, Magdolen V, Schilling O. Shahinian H, et al. Among authors: loessner d. Mol Oncol. 2014 Feb;8(1):68-82. doi: 10.1016/j.molonc.2013.09.003. Epub 2013 Oct 1. Mol Oncol. 2014. PMID: 24120346 Free PMC article.

2

Combined expression of KLK4, KLK5, KLK6, and KLK7 by ovarian cancer cells leads to decreased adhesion and paclitaxel-induced chemoresistance.

Loessner D, Quent VM, Kraemer J, Weber EC, Hutmacher DW, Magdolen V, Clements JA. Loessner D, et al. Gynecol Oncol. 2012 Dec;127(3):569-78. doi: 10.1016/j.ygyno.2012.09.001. Epub 2012 Sep 8. Gynecol Oncol. 2012. PMID: 22964375

3

Metastasis of ovarian cancer is mediated by kallikrein related peptidases.

Dong Y, Loessner D, Irving-Rodgers H, Obermair A, Nicklin JL, Clements JA. Dong Y, et al. Among authors: loessner d. Clin Exp Metastasis. 2014 Jan;31(1):135-47. doi: 10.1007/s10585-013-9615-4. Epub 2013 Sep 17. Clin Exp Metastasis. 2014. PMID: 24043563 Free PMC article. Review.

4

Kallikrein-related peptidases represent attractive therapeutic targets for ovarian cancer.

Loessner D, Goettig P, Preis S, Felber J, Bronger H, Clements JA, Dorn J, Magdolen V. Loessner D, et al. Expert Opin Ther Targets. 2018 Sep;22(9):745-763. doi: 10.1080/14728222.2018.1512587. Epub 2018 Sep 6. Expert Opin Ther Targets. 2018. PMID: 30114962 Review.

5

Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer.

Wang P, Magdolen V, Seidl C, Dorn J, Drecoll E, Kotzsch M, Yang F, Schmitt M, Schilling O, Rockstroh A, Clements JA, Loessner D. Wang P, et al. Among authors: loessner d. Br J Cancer. 2018 Oct;119(7):1-9. doi: 10.1038/s41416-018-0260-1. Epub 2018 Oct 5. Br J Cancer. 2018. PMID: 30287916 Free PMC article.

6

Growth of confined cancer spheroids: a combined experimental and mathematical modelling approach.

Loessner D, Flegg JA, Byrne HM, Clements JA, Hutmacher DW. Loessner D, et al. Integr Biol (Camb). 2013 Mar;5(3):597-605. doi: 10.1039/c3ib20252f. Integr Biol (Camb). 2013. PMID: 23388834

7

The kallikrein-related peptidase family: Dysregulation and functions during cancer progression.

Kryza T, Silva ML, Loessner D, Heuzé-Vourc'h N, Clements JA. Kryza T, et al. Among authors: loessner d. Biochimie. 2016 Mar;122:283-99. doi: 10.1016/j.biochi.2015.09.002. Epub 2015 Sep 4. Biochimie. 2016. PMID: 26343558 Review.

8

Dong Y, Tan OL, Loessner D, Stephens C, Walpole C, Boyle GM, Parsons PG, Clements JA. Dong Y, et al. Among authors: loessner d. Cancer Res. 2010 Apr 1;70(7):2624-33. doi: 10.1158/0008-5472.CAN-09-3415. Epub 2010 Mar 23. Cancer Res. 2010. PMID: 20332224

9

Bioengineered 3D platform to explore cell-ECM interactions and drug resistance of epithelial ovarian cancer cells.

Loessner D, Stok KS, Lutolf MP, Hutmacher DW, Clements JA, Rizzi SC. Loessner D, et al. Biomaterials. 2010 Nov;31(32):8494-506. doi: 10.1016/j.biomaterials.2010.07.064. Epub 2010 Aug 14. Biomaterials. 2010. PMID: 20709389

10

Reactivation of embryonic nodal signaling is associated with tumor progression and promotes the growth of prostate cancer cells.

Lawrence MG, Margaryan NV, Loessner D, Collins A, Kerr KM, Turner M, Seftor EA, Stephens CR, Lai J; APC BioResource; Postovit LM, Clements JA, Hendrix MJ. Lawrence MG, et al. Among authors: loessner d. Prostate. 2011 Aug 1;71(11):1198-209. doi: 10.1002/pros.21335. Epub 2011 Jan 12. Prostate. 2011. PMID: 21656830 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters